Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-20-023248

Corporate Executive VP & CFO sold 3,304 shares at an average $216.54 ($715,444)

  • Corporate Executive VP & CFO acquired 3,304 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Smith David Ross · Corporate Executive VP & CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-07 Exercise or conversion : show line 1 in the form +3,304 $144.67 $477,990 24,071 D
2020-08-07 Sale : show line 2 in the form −2,297 $216.42 $497,110 21,774 D
2020-08-07 Sale : show line 3 in the form −1,007 $216.82 $218,334 20,767 D
Open-market sales · 3,304 sh · avg $216.54 · $715,444

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-08-07 Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) −3,304 9,914 D
Loading xslF345X03/form4.xml…